A detailed history of Saturna Capital Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Saturna Capital Corp holds 24,534 shares of EW stock, worth $1.66 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
24,534
Previous 22,916 7.06%
Holding current value
$1.66 Million
Previous $2.12 Million 23.53%
% of portfolio
0.02%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$59.7 - $93.78 $96,594 - $151,736
1,618 Added 7.06%
24,534 $1.62 Million
Q2 2024

Jul 31, 2024

BUY
$84.3 - $94.31 $25,711 - $28,764
305 Added 1.35%
22,916 $2.12 Million
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $80,446 - $105,976
1,109 Added 5.16%
22,611 $2.16 Million
Q4 2023

Feb 06, 2024

SELL
$61.71 - $77.76 $7,405 - $9,331
-120 Reduced 0.55%
21,502 $1.64 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $27,365 - $36,885
-395 Reduced 1.79%
21,622 $1.5 Million
Q2 2023

Aug 04, 2023

BUY
$81.41 - $94.33 $185,614 - $215,072
2,280 Added 11.55%
22,017 $2.08 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $84,062 - $95,665
1,132 Added 6.08%
19,737 $1.63 Million
Q4 2022

Feb 09, 2023

SELL
$68.3 - $87.44 $104,499 - $133,783
-1,530 Reduced 7.6%
18,605 $1.39 Million
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $4,118 - $5,364
50 Added 0.25%
20,135 $1.66 Million
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $30,275 - $44,894
350 Added 1.77%
20,085 $1.91 Million
Q1 2022

May 10, 2022

SELL
$101.96 - $128.34 $385,408 - $485,125
-3,780 Reduced 16.07%
19,735 $2.32 Million
Q4 2021

Feb 09, 2022

BUY
$106.37 - $130.68 $31,911 - $39,204
300 Added 1.29%
23,515 $3.05 Million
Q3 2021

Nov 08, 2021

SELL
$102.91 - $122.75 $28,814 - $34,370
-280 Reduced 1.19%
23,215 $2.63 Million
Q2 2021

Aug 11, 2021

BUY
$83.84 - $104.76 $33,536 - $41,904
400 Added 1.73%
23,495 $2.43 Million
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $33,045 - $38,081
420 Added 1.85%
23,095 $1.93 Million
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $35,845 - $45,615
500 Added 2.25%
22,675 $2.07 Million
Q3 2020

Nov 10, 2020

BUY
$67.19 - $87.44 $13,438 - $17,488
200 Added 0.91%
22,175 $1.77 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $842,961 - $1.13 Million
14,650 Added 200.0%
21,975 $1.52 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $13,102 - $20,250
250 Added 3.53%
7,325 $1.57 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $3,077 - $3,771
50 Added 0.71%
7,075 $1.56 Million
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $6,855 - $8,704
-150 Reduced 2.09%
7,025 $1.22 Million
Q1 2018

May 10, 2018

SELL
$37.19 - $47.45 $92,975 - $118,625
-2,500 Reduced 25.84%
7,175 $1 Million
Q4 2017

Feb 06, 2018

BUY
$33.79 - $39.39 $6,758 - $7,878
200 Added 2.11%
9,675 $1.09 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $9,979 - $10,678
275 Added 2.99%
9,475 $996,000
Q2 2017

Aug 14, 2017

BUY
N/A
9,200
9,200 $1.09 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.